Calidi Biotherapeutics Inc (CLDI)
2.12
-1.26
(-37.28%)
USD |
NYAM |
Nov 14, 12:33
Calidi Biotherapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.1582 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.1582
Minimum
Dec 2021
-0.1582
Maximum
Dec 2021
-0.1582
Average
-0.1582
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Lumos Pharma Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.431M |
| Total Liabilities (Quarterly) | 18.18M |
| Shareholders Equity (Quarterly) | -11.75M |